Form 4: Recursion Pharmaceuticals Director Acquires Shares Under Compensation Policy

Director Blake Borgeson acquired 1,441 shares of Recursion Pharmaceuticals' Class A Common Stock on July 1, 2024, under the company's Outside Director Compensation Policy.

Summary

• On July 1, 2024, Blake Borgeson, a director of Recursion Pharmaceuticals, acquired 1,441 shares of Class A Common Stock.
• The acquisition was made under the Issuer's Outside Director Compensation Policy.
• The price per share was $0.
• Following the transaction, Borgeson directly owns 7,178,557 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's acquisition of shares suggests confidence in the company, but it's a routine transaction under a compensation policy.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of a transaction by a company insider, as required by the SEC. It provides transparency into the actions of company leadership.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates